
In this Three Breakthroughs episode of the Alumni Ventures Tech Optimist Podcast, host Mike Collins and Lucas Pasch explore three transformative advancements shaping the future. First, they break down the AI arms race, where tech giants like Google, Microsoft, and Amazon are pouring tens of billions into AI infrastructure, fueling competition and raising questions about market concentration and innovation. Next, they examine the unbundling of social media, with platforms like BlueSky gaining traction by offering decentralized, user-controlled experiences that challenge Big Tech’s dominance. Finally, they dive into a groundbreaking cancer vaccine trial from Dana-Farber, where personalized immunotherapy has delivered astonishing results—zero recurrences in advanced kidney cancer patients after three years. These breakthroughs are redefining industries and opening new possibilities for technology, medicine, and digital interaction. Tune in for a forward-looking discussion on where these shifts are headed next!To Learn More:Alumni Ventures (AV)AV LinkedInAV Deep Tech FundTech OptimistLegal Disclosure:https://av-funds.com/tech-optimist-disclosuresCreators & Guests Mike Collins - Host Lucas Pasch - Guest Shail Highbloom - Producer Sam Herrick - Producer Keith Murphy - Producer Jeannie Masters - Producer
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

#102 - Meet the Startup Transforming CO₂ Into Synthetic Fuels

#100 - 100 Episodes of Optimism: A Look Back at Our Best Moments

#99 - Three Breakthroughs: Big AI vs Little AI

#98 - Meet the Startup Offering Developers a Toolkit To Resolve Their Most Pressing Problems
Free AI-powered recaps of Tech Optimist: An Alumni Ventures Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.